摘要
目的分析临床路径管理模式对控制医疗不良因素及医疗纠纷的效果。方法采用前瞻性研究方法,随机选择2018年5月—2020年8月于甘肃省人民医院住院的按临床路径模式管理的21个病种519例患者作为观察组,选择同时期按常规化模式管理的患同种疾病的672例患者作为对照组,比较两组医疗纠纷的发生率,从医方诊疗及管理因素、患方因素、医患沟通因素、疾病自身因素4个方面分析医疗纠纷不良因素。结果观察组医疗纠纷总发生率为10.2%,低于对照组的25.4%,差异有统计学意义(P<0.05)。观察组和对照组因医方因素、患方因素、医患共同因素、疾病自身因素引发的医疗纠纷发生率分别为5.4%和14.0%、2.8%和5.4%、0.6%和2.2%、1.8%和3.4%。结论临床路径管理模式能有效控制医疗不良因素,减少医疗纠纷发生。
Objective To analyze the effect of clinical pathway management model on controlling adverse medical factors and medical disputes.Methods The prospective study was used 519cases of 21 diseases managed by clinical pathway mode in Gansu Provincial People’s Hospital from May 2018 to August 2020 were randomly selected as the observation group,and 672 cases of the same disease managed by conventional management mode in the same period were selected as the control group.The incidence of medical disputes between the two groups was compared in the four aspects of medical diagnosis and management factors,patient factors,doctor-patient communication factors and disease itself factors.Results The total incidence of medical disputes in the observation group was 10.2%,which was lower than 25.4% in the control group,and the difference was statistically significant(P<0.05).The incidences of medical disputes in the observation group and the control group,caused by medical factors,patient factors,common factors of doctors and patients and disease itself,were respectively 5.4%and 14.0%,2.8% and 5.4%,0.6% and 2.2%,1.8% and 3.4%.Conclusion Clinical pathway management model can effectively control adverse medical factors and reduce medical disputes.
作者
马国胜
彭彩丽
康兰
沈燕飞
刘继新
徐福穗
陈红刚
MA Guosheng;PENG Caili;KANG Lan;SHEN Yanfei;LIU Jixin;XUFusui;CHEN Honggang(Divison of Medical Affairs,Gansu Provincial People's Hospital,Lanzhou Gansu 730000,China)
出处
《中国卫生标准管理》
2022年第8期97-101,共5页
China Health Standard Management
基金
兰州市科技发展指导性计划项目(2017-ZD-41)。
关键词
临床路径
常规化模式
医疗纠纷
不良因素
管理模式
控制
clinical Pathway
conventional management
medical disputes
adverse factors
management model
controlling
